News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Erman Akkus Summarizes 5-year Results of CheckMate 040
May 24, 2024, 13:24

Erman Akkus Summarizes 5-year Results of CheckMate 040

Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X:

“Nivolumab plus ipilimumab after sorafenib in patients with advanced HCC
5-year results of CheckMate 040
Annals of Oncology

Nivolumab 1 mg/kg plus ipilimumab 3 mg/kg Q3W (four doses), followed by nivolumab 240 mg Q2W

  • ORR: 34%
  • mDOR: 51.2 mo
  • mOS: 22.2 mo
  • 60-month OS rate: 29%″

Erman Akkus

Read the article.
Source: Erman Akkus/X
.

5-year results advanced HCC Annals of Oncology cancer cancer therapy cancer treatment CheckMate 040 clinical trial Erman Akkus Healthcare Research hepatocellular carcinoma immunotherapy ipilimumab mDoR median duration of response median overall survival mOS nivolumab objective response rate OncoDaily Oncology oncology research ORR Research sorafenib survival rates
Special Coverage
Blog
Dec 30, 2024, 13:25
Sanjay Popat: Wouldn’t it be great if FDA Oncology approvals were mutually approvable by MHRA?
Insight
Dec 30, 2024, 13:23
Satya Prakash Yadav: 2024 blockbuster Menin inhibitor for infant ALL
Insight
Dec 30, 2024, 13:10
Promising response to lurbinectedin in NUT carcinoma by M.V. Sánchez Becerra et al. - Vivek Subbiah
Blog
Dec 30, 2024, 13:08
Cathy Eng: Congrats to Pfizer and all the colorectal cancer patients with treatment-naive metastatic CRC
Blog
Dec 30, 2024, 13:06
Let’s celebrate responsibly: Your health is your greatest wealth - European Liver Patients'​ Association
Blog
Dec 30, 2024, 12:58
Gevorg Tamamyan: ADCO YIA for Survivorship research need everyone's support
Insight
Dec 30, 2024, 12:39
When Diversity Goals Meet Multiregional Trials by Gautam Mehta et al. - FDA Oncology
Blog
Dec 30, 2024, 12:36
Jean Kaseya: No one serving humanity should endure violence
Insight
Dec 30, 2024, 12:33
Patrick Hwu: Why treating neurological disorders like brain tumors is difficult
Insight
Dec 30, 2024, 12:29
Laura Bukavina: No significant link was found between plant-based or animal-based protein intake and bladder cancer risk
Science
Dec 30, 2024, 12:25
Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer
Science
Dec 30, 2024, 12:08
Nicholas Short: Measurable residual disease monitoring in AML